FDA Unapproved Drugs: The $7.5 Billion 505(b)(2) Opportunity Most Pharma Execs Are Ignoring DrugPatentWatch Transform Data into Market Domination Unauthorized injectable peptide drugs sold by Prime Research may pose serious health risks Canada.ca FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA releases denial letters for unapproved drugs, a step toward transparency